Dvago Logo
    location icon

    Dvago Logo

    Delivers in

      location icon

      crafilm chewable tablets 250mg/100mg (1 box = 4 strips) (1 strip = 8 tablets) Product Image

      Crafilm Chewable Tablets 250Mg/100Mg (1 Box = 4 Strips) (1 Strip = 8 Tablets)

      Rs. 294.72

      Rs. 310.08



      Crafilm Chewable Specification

      Requires Prescription (YES/NO)



      Sucralfate , Calcium Carbonate

      Used For

      Acidity & Heartburn

      How it works

      Sucralfate is a sucrose sulfate-aluminum complex that possesses cytoprotective properties. It prevents direct contact of hydrochloric acid (HCl) with the inner mucosa by binding to the ulcer. It also acts like an acid buffer by promoting bicarbonate production.Calcium carbonate is an antacid that combats hyperacidity by neutralizing HCl.

      Crafilm Chewable Usage And Safety


      Sucralfate , Calcium Carbonate

      Side Effects

      Constipation , diarrhoea , GI upset , dry mouth , rash.

      Drug Interactions

      Tetracyclines , phenytoin , cimetidine , digoxin .


      It is a proven therapy for a myriad of gastrointestinal problems causing indigestion, acidity and heartburn. It is a gastric mucosal protectant that works by forming a barrier against gastric acid, enzymes and salts. It is indicated in: Heart burn, Hyperacidity, Peptic and duodenal ulcer, Bloating & Belching and Dyspepsia.

      When not to Use

      Hypersensitivity to sucralfate or to any of the excipients found in this product.

      Crafilm Chewable Precautions


      It should be administered with caution in patients with renal impairment or on dialysis, due to the possibility of increased aluminium absorption.

      Crafilm Chewable Warnings

      Warning 1

      Aluminium accumulation and toxicity (aluminium osteodystrophy, osteomalacia, encephalopathy) have been described in patients with renal impairment. Blood levels of aluminium, phosphate, calcium, alkalinephosphatase, should be periodically measured in these patients.

      Warning 2

      Caution is advised when sucralfate is administered in patients with phosphate deficiencies as aluminium binds to phosphate in the gastrointestinal tract, inhibiting its absorption.

      Warning 3

      Occasional cases of bezoar (an insoluble mass formed within the gastric lumen) have been reported in patients taking sacralfate. Bezoars have been described in patients after administration of sucralfate in severely ill patients in Intensive Care Units, and especially in premature infants in whom the use of sucralfate is not recommended, and should be used with caution in patients with delayed gastric emptying or receiving concomitant enteral feeds.

      Crafilm Chewable Additional Information

      Pregnancy category

      Always consult your physician before using any medicine.

      Storage (YES/NO)

      Store this medicine at room temperature, away from direct light and heat.

      Related Products